Myocardial fat deposition after left ventricular myocardial infarction: Assessment by using MR water-fat separation imaging

Radiology

Volumn 253, Issue 1, 2009, Pages 65-73

  Goldfarb, James W ^a,b   Roth, Marguerite ^a   Han, Jing ^a  

^a ST FRANCIS HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; GADOLINIUM; WATER; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART VENTRICLE WALL MOTION; HUMAN; IMAGE RECONSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADIPOSE TISSUE; COMPUTER ASSISTED TOMOGRAPHY; HEART VENTRICLE; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEART VENTRICLES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350508408     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2532082290     Document Type: Article

References (40)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-1172.
2. Bilheimer DW, Buja LM, Parkey RW, Bonte FJ, Willerson JT. Fatty acid accumulation and abnormal lipid deposition in peripheral and border zones of experimental myocardial infarcts. J Nucl Med 1978;19:276-283.
3. Goldfarb JW, Arnold S, Roth M, Han J. T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction. Magn Reson Med 2007;57:828-834.
4. Baroldi G, Silver MD, De Maria R, Parodi O, Pellegrini A. Lipomatous metaplasia in left ventricular scar. Can J Cardiol 1997;13: 65-71.
5. Pantanowitz L. Fat infiltration in the heart. Heart 2001;85:253.
6. Roberts WC, Roberts JD. The floating heart or the heart too fat to sink: analysis of 55 necropsy patients. Am J Cardiol 1983;52: 1286-1289.
7. Crocker DW. Lipomatous infiltrates of the heart. Arch Pathol Lab Med 1978;102:69-72.
8. Burke AP, Farb A, Tashko G, Virmani R. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998;97:1571-1580.
9. Jain A, Tandri H, Calkins H, Bluemke DA. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 2008; 10:32.
10. Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277-2284.
11. Su L, Siegel JE, Fishbein MC. Adipose tissue in myocardial infarction. Cardiovasc Pathol 2004;13:98-102.
12. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194.
13. Wang Y, Li D, Haacke EM, Brown JJ. A three-point Dixon method for water and fat separation using 2D and 3D gradient-echo techniques. J Magn Reson Imaging 1998;8: 703-710.
14. He T, Gatehouse PD, Kirk P, et al. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging 2007;25:1205-1209.
15. Goldfarb JL. Fat-water separated delayed hyperenhanced myocardial infarct imaging. Magn Reson Med 2008;603:503-509.
16. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383.
17. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-514.
18. Hsu LY, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. II. Clinical application of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23: 309-314.
19. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-2389.
20. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-542.
21. Goldfarb JW. Fat deposition in the myocardium of the left ventricle. J Cardiovasc Magn Reson 2007;9:605-606.
22. Heatlie G, Cornelius BC, Kilkowski A, Prasad S, Sheppard MN, Mohiaddin R. Unusual fatty infiltration of the basal left ventricle. J Cardiovasc Magn Reson 2006;8:405-406.
23. Ramage EJ, Reid JH, Hardwick D. Subendocardial fat: an unusual finding. Clin Radiol 2003;58:816-817.
24. Voigt J, Agdal N. Lipomatous infiltration of the heart. An uncommon cause of sudden, unexpected death in a young man. Arch Pathol Lab Med 1982;106:497-498.
25. Winer-Muram HT, Tann M, Aisen AM, Ford L, Jennings SG, Bretz R. Computed tomography demonstration of lipomatous metaplasia of the left ventricle following myocardial infarction. J Comput Assist Tomogr 2004;28: 455-458.
26. Schmitt M, Samani N, McCann G. Images in cardiovascular medicine: lipomatous metaplasia in ischemic cardiomyopathy - a common but unappreciated entity. Circulation 2007;116:e5-e6.
27. Nijveldt R, Marcu CB, van Rossum AC. Lipomatous metaplasia in myocardial infarction detected by cardiovascular magnetic resonance. Heart 2006;92:1337.
28. Zafar HM, Litt HI, Torigian DA. CT imaging features and frequency of left ventricular myocardial fat in patients with CT findings of chronic left ventricular myocardial infarction. Clin Radiol 2008;63:256-262.
29. Reeves RC, Evanochko WT, Canby RC, McMillin JB, Pohost GM. Demonstration of increased myocardial lipid with postischemic dysfunction ("myocardial stunning") by proton nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 1989;13:739-744.
30. Miller DD, Gill JB, Livni E, et al. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988;63:681-692.
31. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411-2416.
32. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-1870.
33. Keegan J, Gatehouse PD, Prasad SK, Firmin DN. Improved turbo spin-echo imaging of the heart with motion-tracking. J Magn Reson Imaging 2006;24:563-570.
34. Vignaux OB, Augui J, Coste J, et al. Comparison of single-shot fast spin-echo and conventional spin-echo sequences for MR imaging of the heart: initial experience. Radiology 2001;219:545-550.
35. Yan AT, Gibson CM, Larose E, et al. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson 2006;8:831-837.
36. Fernandes VR, Wu KC, Rosen BD, et al. Enhanced infarct border zone function and altered mechanical activation predict inducibility of monomorphic ventricular tachycardia in patients with ischemic cardiomyopathy. Radiology 2007;245:712-719.
37. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007; 115:2006-2014.
38. Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, Francis JM. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson 2007;9:777-783.
39. Cheng AS, Robson MD, Neubauer S, Selvanayagam JB. Irreversible myocardial injury: assessment with cardiovascular delayed-enhancement MR imaging and comparison of 1.5 and 3.0 T-initial experience. Radiology 2007;242:735-742.
40. Tatli S, Zou KH, Fruitman M, et al. Three-dimensional magnetic resonance imaging technique for myocardial-delayed hyperenhancement: a comparison with the two-dimensional technique. J Magn Reson Imaging 2004; 20:378-382.